Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A lasting legacy.
Ginn S. Ginn S. Lancet. 2024 Apr 20;403(10436):1532. doi: 10.1016/S0140-6736(24)00760-8. Lancet. 2024. PMID: 38642943 No abstract available.
Novel AAV variants with improved tropism for human Schwann cells.
Drouyer M, Chu TH, Labit E, Haase F, Navarro RG, Nazareth D, Rosin N, Merjane J, Scott S, Cabanes-Creus M, Westhaus A, Zhu E, Midha R, Alexander IE, Biernaskie J, Ginn SL, Lisowski L. Drouyer M, et al. Among authors: ginn sl. Mol Ther Methods Clin Dev. 2024 Mar 11;32(2):101234. doi: 10.1016/j.omtm.2024.101234. eCollection 2024 Jun 13. Mol Ther Methods Clin Dev. 2024. PMID: 38558569 Free PMC article.
Development of new adeno-associated virus capsid variants for targeted gene delivery to human cardiomyocytes.
Kok CY, Tsurusaki S, Cabanes-Creus M, Igoor S, Rao R, Skelton R, Liao SHY, Ginn SL, Knight M, Scott S, Mietzsch M, Fitzsimmons R, Miller J, Mohamed TMA, McKenna R, Chong JJH, Hill AP, Hudson JE, Alexander IE, Lisowski L, Kizana E. Kok CY, et al. Among authors: ginn sl. Mol Ther Methods Clin Dev. 2023 Aug 18;30:459-473. doi: 10.1016/j.omtm.2023.08.010. eCollection 2023 Sep 14. Mol Ther Methods Clin Dev. 2023. PMID: 37674904 Free PMC article.
Dark matter.
Ginn S. Ginn S. Lancet. 2023 Aug 5;402(10400):443. doi: 10.1016/S0140-6736(23)01578-7. Lancet. 2023. PMID: 37543412 No abstract available.
Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma.
Wolfe Z, Friedland JC, Ginn S, Blackham A, Demberger L, Horton M, McIntosh A, Sheikh H, Box J, Knoerzer D, Federowicz B, Stuhlmiller TJ, Shapiro M, Nair S. Wolfe Z, et al. Among authors: ginn s. Melanoma Res. 2022 Aug 1;32(4):295-298. doi: 10.1097/CMR.0000000000000830. Epub 2022 May 12. Melanoma Res. 2022. PMID: 35551160 Free PMC article.
Curative Cell and Gene Therapy for Osteogenesis Imperfecta.
Schindeler A, Lee LR, O'Donohue AK, Ginn SL, Munns CF. Schindeler A, et al. Among authors: ginn sl. J Bone Miner Res. 2022 May;37(5):826-836. doi: 10.1002/jbmr.4549. Epub 2022 Apr 17. J Bone Miner Res. 2022. PMID: 35306687 Free PMC article. Review.
95 results